DUBLIN--(BUSINESS WIRE)--The "US Clinical Laboratory Testing Market by Type of Test (Tumor, Clinical Chemistry, Microbiology, Esoteric), by Type of Lab (Hospital, Physician, Independent), & by Type of Diseases (Tuberculosis, Influenza, Cancer, HIV/AIDS etc.), Forecast to 2022" report has been added to ResearchAndMarkets.com's offering.
The US represents an attractive destination for healthcare services' market segments, especially clinical lab testing, which has evolved as a major source of the decisive factor for healthcare professionals and that too despite garnering a low proportion of total medical spending.
It is estimated that the market for clinical lab testing in the US is poised to witness healthy growth backed by factors such as the aging population, active private sector participation, and rising awareness level. With the emergence of new technologies, the market is likely to register further to an optimum CAGR in the future.
Currently, the market is dominated by clinical chemistry tests, followed by human & tumor genomics. The future, however, holds significant promise for human and tumor genomics testing. The future growth in this segment is driven by strong growth in personalized laboratory testing on tumor tissues and other key factors. The report, in this context, offers effective information and analysis on the market landscape for key tests type, with special emphasis on their future performance.
Moreover, the report provides the current and future markets for different types of tests. The report also divides the market on the basis of types of labs into hospital-based laboratories, physician laboratories, and independent laboratories. The physician laboratories accounted for the largest share in the US clinical laboratory testing market in 2016.
The US market for clinical laboratory diagnostics is highly fragmented, with a large number of labs offering services in different states of the country. Some players, however, have the leading edge in comparison to other companies. Quest Diagnostics, LabCorp and Sonic Healthcare are the key independent laboratories that have augmented their reach in the market with proper focus on consolidation activities.
This report provides an in-depth insight into the operations, services, financial performance of the key players in order to gauge their attractiveness in terms of investment and future participation in the market. Overall, the report is likely to be proved beneficial for all those entities who want to enter the market or make decisions regarding investment.
Key Topics Covered
1. Analyst View
2. Research Methodology
3. US Clinical Laboratory Testing Market Outlook 2022
4. Market Segmentation by Test Type
4.1 Clinical Chemistry Laboratory
4.2 Human & Tumor Genetics Laboratory
4.3 Medical Microbiology & Cytology Laboratory
4.4 Esoteric Tests
5. Market Segmentation by Laboratories
5.1 Hospital Laboratories
5.2 Physician Laboratories
5.3 Independent Laboratories
6. Disease Demographics
7. Drivers & Trends
7.1 Growing Ageing Population
7.2 Rising Disease Incidence
7.3 Early Disease Detection Facilities
7.4 Employer Wellness Programs
7.5 Increased Health Care Spending
7.6 Collaboration & Consolidation
7.7 Focusing on Innovations
8. Key Players
8.1 Laboratory Corporation of America (LabCorp)
8.2 OPKO Health Inc.
8.3 Sonic Healthcare USA
8.4 Quest Diagnostics
8.5 Alere Inc.
8.6 Abbott Laboratories
8.7 Charles River Laboratories
8.8 Healthscope Ltd.
8.9 Genzyme (Subsidiary of Sanofi)
For more information about this report visit https://www.researchandmarkets.com/r/2pbsdb